Pharmaceuticals
Zymes LLC has exclusive worldwide rights to Ubisol-Aqua™, a solubilization technology developed at the National Research Council (NRC) of Canada. Ubisol-Aqua™ is a patented family of molecules that serves as novel carriers for water insoluble compounds. The Ubisol-Aqua™ technology achieves solubilization, enhancing the functionality of drugs and providing a wide range of delivery applications unavailable to water insoluble compounds. The vast applicability of Ubisol-Aqua™ has been demonstrated in the following categories:
- Improved Solubility
- Enhanced Bioavailability
- Alternative Delivery Routes
- Reformulation of Drugs
- Ubisol-Aqua™ as a Pro-drug
Zymes LLC presents this new approach for licensing to pharmaceutical partners.